At a glance
ClinicalIndex Comparison RecordN/ACompleted· 176 enrolled
Drug / intervention
JUVÉDERM® VOLBELLA® XC with Lidocaine +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Multicenter, No-treatment Controlled Study of the Safety and Effectiveness of JUVÉDERM® VOLBELLA® With Lidocaine for Lip Enhancement in Chinese Adults
In Brief
A clinical study evaluating JUVÉDERM® VOLBELLA® XC with Lidocaine and No-treatment Control for Lip Enhancement. Completed, enrolled 176 participants across 5 sites.
Detailed Summary
This study will evaluate the safety and effectiveness of VOLBELLA with Lidocaine injectable gel in Chinese adults seeking lip enhancement.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLip Enhancement
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartJan 2016
Primary CompletionMar 2018
First PostedMay 2018
TodayJul 2026
First PostedMay 8, 2018
Enrollment StartJan 28, 2016
Primary CompletionMar 30, 2018
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 8.2 years ago
Interventions
JUVÉDERM® VOLBELLA® XC with Lidocainedevice
JUVÉDERM® VOLBELLA® XC with lidocaine injected into lips.
No-treatment Controlother
No-treatment was administered.